Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam on Working Memory in Glioma Patients
NCT07109362Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Behavioral results (d', reaction time and accuracy rate) and P3b event-related potential amplitude. Started Aug 2025; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT07109362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07109362.